United States
The Dallas Fed survey points to strengthening manufacturing activity alongside moderating price pressures. The headline index rose to 0.2 from -1.2, beating estimates and marking the strongest reading since July 2025, though still at a low level. The index…
Trump is saving face with new tariffs but will avoid any major new tariff shock until 2027. For now, Iran risk will overshadow tariff volatility.
The December US Personal Income and Outlays report sent mixed signals. Real consumption slowed to 0.1% m/m from 0.2% in November, in line with expectations, while real income excluding transfers fell 0.1%. Spending was supported by dissaving, with the saving…
February flash PMIs edged higher, pointing to gradual improvement in global growth. After moving mostly sideways through 2025, developed markets PMIs are picking up. Manufacturing is showing decent momentum, rebounding after being weighed down by trade…
US checks and balances are still in place. The Supreme Court ruled against the Trump administration's use of sweeping tariffs under the International Emergency Economic Powers Act (IEEPA). Our US and Geopolitical strategists see different implications for the…
The February Philly Fed survey signaled expanding manufacturing activity alongside disinflationary pressures. The index rose to 16.3 from 12.6, beating estimates, and the general expectations measure also ticked up. Monthly manufacturing surveys are volatile,…
Relative macro momentum suggests scope for US tactical equity outperformance versus Europe. Just as macro momentum drives cross-asset returns, relative momentum helps explain cross-country equity performance. A simple measure is the difference in economic…
A Supreme Court strike-down of tariffs could still leave scope for President Trump to reinstate them under different statutes, while allowing a net reduction in tariff rates ahead of the midterms. Barring any major data surprise or US strikes on Iran, the…
The February Empire survey points to expanding manufacturing activity, adding to signs of improving macro momentum. The headline index was little changed at 7.1 and slightly beat estimates. New orders moderated but remained in expansion, while shipments…
The capex debate is better framed not as boom versus bubble, but as around capacity, leverage, and cash conversion. ROEs have compressed, but revenue growth and margin expansion offer a credible path back. Spenders likely have time to make good on their investments, though the market’s leash may be shorter than anticipated.